Patient Detail: Registration Location: Reference: Patient Number:

Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,
Collection DateTime: 17-Jun-2025 10:48
Department of Virology Reporting DateTime: 17-Jun-2025 21:09

Serum HBsAg

Non-Reactive
Cutoff
Value 1.0
Patient
Value 0.29
Non Reactive <1.0 | Reactive ≥ 1.0

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
Interpretation:
• Hepatitis B surface antigen (HBsAg) test is one of the triple panel screening tests, which also includes antibody to hepatitis B
surface antigen (anti-HBs), and total antibody to hepatitis B core antigen (total anti-HBc).
• HBsAg usually becomes undetectable after four to six months in acute infection, whereas persistence of HBsAg for more than six
months indicates chronic infection.
• A reactive result indicates an ongoing HBV infection, acute or chronic.
• A non-reactive result does not rule out the possibility of HBV exposure or infection as it may be seen in severely immuno-
compromised patients, patients on dialysis, or HBsAg mutants.
• False positive results may be due to heterophilic antibodies in human serum and after a dose of HBV vaccine.
Methodology: HBsAg test is performed on fully automated Chemiluminescence Microparticles Immunoassay Analyzer (CMIA),
Abbott Alinity i.
Reference: Centers for Disease Control and Prevention - Screening and Testing Recommendations for Chronic Hepatitis B Virus
Infection (HBV)
Note: Two lab intercomparison cannot be done due to difference in sample collection, transportation, storage, sensitivity, and
specificity of assay.

Serum Anti-HCV

Non-Reactive
Cutoff
Value 1.00
Patient
Value 0.09
Non Reactive < 1.0 | Reactive ≥ 1.0

Interpretation:
• Anti-HCV is a screening test for Hepatitis C which detects antibodies to Hepatitis C virus (HCV) infection.
• A reactive result indicates that the patient has evidence of acquisition of the HCV infection, particular chronic HCV infection, and
it should be followed by HCV RNA testing.
• A non-reactive result does not rule out the possibility of HCV exposure or infection as it may be seen in severely immuno-
compromised patients, patients on dialysis, or acute HCV infection.
• False positive results, though less frequent, may be due to passively acquired anti-HCV antibodies from blood transfusions,
heterophile antibodies, or cross-reactivity with other viral infections.
Methodology: Anti-HCV test is performed on fully automated Chemiluminescence Microparticles Immunoassay Analyzer (CMIA),
Abbott Alinity i.
Reference: Centers for Disease Control and Prevention - CDC Recommendations for Hepatitis C Screening Among Adults
Note: Two lab intercomparison cannot be done due to difference in sample collection, transportation, storage, sensitivity, and
specificity of assay.

Dr. Hajra Farooq Prof Waheed Uz Zaman Tariq

Fellow Virologist Consultant Virologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com
Patient Detail: Registration Location: Reference: Patient Number:
Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,

Collection DateTime: 17-Jun-2025 10:48

Department of Hematology Reporting DateTime: 17-Jun-2025 19:06

Blood C/E (Complete, CBC)

40718-17-06
Test Reference Value Unit 17-Jun-2025 10:48

Hb 12.3 - 16.6 g/dl 15.9

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
Total RBC 4.25 - 6.02 x10^12/l 6.0
HCT 38 - 52 % 49
MCV 75 - 95 fl 82
MCH 26 - 32 pg 27
MCHC 30 - 35 g/dl 32
RDW CV % 11.5 - 14.5 % 13.9
Platelet Count 150 - 450 x10^9/l 334
MPV fl 7 - 11 fl 10.3
WBC Count (TLC) 4.8 - 11.3 x10^9/l 8.3
Neutrophils 40.0 - 75.0 % 58.8
Lymphocytes 18.0 - 45.0 % 32.7
Monocytes 2.0 - 10.0 % 5.6
Eosinophils 1.0 - 6.0 % 2.2
Basophils Less Than 1.0 % 0.7
Abs. Neutrophils 2.00 - 7.00 x10^9/l 4.90
Abs. Lymphocytes 1.00 - 3.00 x10^9/l 2.73
Abs. Monocytes 0.20 - 1.00 x10^9/l 0.47
Abs. Eosinophils 0.02 - 0.50 x10^9/l 0.18
Abs. Basophils 0.02 - 0.10 x10^9/l 0.06

Dr. Asma Nasir Dr. N. A. Malik

Consultant Hematologist Consultan Hematologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com
 Patient Detail: Registration Location: Reference: Patient Number:
Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,

Department of Hematology Collection DateTime:

Reporting DateTime:
17-Jun-2025 10:48
17-Jun-2025 21:13

8.5
ESR

7
8
7.5
7 7 mm/1st H
6.5
6 Normal

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
5.5
(40718-17-06)
17/06/2025

Normal (≤10) High (>10)

Dr. Asma Nasir Dr. N. A. Malik

Consultant Hematologist Consultan Hematologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com
 Patient Detail: Registration Location: Reference: Patient Number:
Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,

Department of Chemical Pathology Collection DateTime:

Reporting DateTime:
17-Jun-2025 10:48
17-Jun-2025 17:58

100
Plasma Glucose (Fasting)

86
95

A blood sample requires fasting of 12 hours. High blood glucose 90

level can be found in people with diabetes, critical medical 85 86

mg/dL
conditions, as well as pregnant women with gestational diabetes. 80
Low blood glucose level commonly affects people with diabetes, 75 Normal

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
rarely it can also occur as a result of other underlying conditions. 70
(40718-17-06)
17/06/2025

Hypoglycemia (<70) Normal (70 - 99) Prediabetes (100 - 126) Diabetes Mellitus (>126)

Note: Change in reference values is effective from 24 August 2021.

Reference : American Diabetes Association (ADA). Standards of medical care in diabetes - 2017

Serum Uric Acid

5.8
6.4

6
5.8 5.8
mg/dL
5.4

5 Normal
(40718-17-06)
17/06/2025

Low (<3.5) Normal (3.5 - 7.29) High (>7.29)

Lipid Profile
350
Serum Total Cholesterol

303
330

310
Cholesterol is essential substance for human body at normal levels. 303
High cholesterol can block blood vessels and can increase the risk of 290 mg/dL
heart disease or a stroke. 270
High
250
(40718-17-06)
17/06/2025

Desirable (<200) Borderline High (200 - 240) High (>240)

220
Serum Triglycerides

189
210

Triglycerides are fats that are a flexible source of energy. High 200
triglyceride levels can be treated by following a lower calorie diet, 190 189 mg/dL
taking regular exercise and medication prescribed by physician. 180
170 Borderline High
160
(40718-17-06)
17/06/2025

Normal (<150) Borderline High (150 - 199) High (200 - 499) Very High (≥500)

Dr. Hijab Batool Dr. M. Dilawar Khan

Consultant Chemical Pathologist Consultant Chemical Pathologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com
 Patient Detail: Registration Location: Reference: Patient Number:
Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,

Serum HDL-Cholesterol

35
40

HDL Cholesterol is known as the "Good" cholesterol because it helps

36
to remove other forms of cholesterol from bloodstream and 35
mg/dL
associated with a lower risk of heart disease.
32
Low
28
(40718-17-06)
17/06/2025

Low (<39) Normal (>40)

Serum LDL-Cholesterol

258
290

270
LDL-C is considered as the primary target of therapy. 258
Target LDL-C for high risk population according to American Heart 250 mg/dL
Association 2024 guidelines is <55 mg/dL.
Risk stratification is based on clinical history of an individual e.g.
230
Very High
ASCVD, diabetes, hypertension, smoking and age. 210
(40718-17-06)
17/06/2025
If you are currently taking a lipid lowering drug, please consult your
physician before changing dosage.

Desirable (<100) Above Desirable (100 - 129) Borderline High (130 - 159) High (160 - 189) Very High (≥190)

Serum Non-HDL Cholesterol

268
300

280
Non-HDL-C is considered as the secondary target of therapy, and 268
according to American Heart Association 2024 guidelines, target non- 260 mg/dL
HDL-C is <100 mg/dL for high risk population.
Risk stratification is based on clinical history of an individual e.g.
240
Very High
220
ASCVD, diabetes, hypertension, smoking and age. (40718-17-06)
17/06/2025

If you are currently taking a lipid lowering drug please consult your
physician before changing dosage.
Desirable (<129) Above Desirable (130 - 159) Borderline High (160 - 189) High (190 - 219) Very High (≥220)

Dr. Hijab Batool Dr. M. Dilawar Khan

Consultant Chemical Pathologist Consultant Chemical Pathologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com
Patient Detail: Registration Location: Reference: Patient Number:
Mr.Anwer Saeed . Near Sheikh Zayad Hospital, Lahore Pyramid Gas & Chemical Service (Activity- Credit)
2801-16-2655491
Age/Sex Mobile # Registration Date: Consultant: Case Number:
46 Y(s) / M - 03214906195 17-Jun-2025 10:48 .SELF 40718-17-06
NIC # : 35202-8762982-3, , ,

Collection DateTime: 17-Jun-2025 10:48

Department of Chemical Pathology Reporting DateTime: 17-Jun-2025 20:29

Liver Function Tests

40718-17-06
Test Reference Value Unit 17-Jun-2025 10:48

Serum Total Bilirubin 0.10 - 1.20 mg/dL 0.7

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
Serum Conjugated Bilirubin UPTO 0.50 mg/dL 0.1
Serum Unconjugated Bilirubin 0.10 - 1.00 mg/dL 0.6
Serum ALT (SGPT) UPTO 45.00 U/L 29
Serum AST (SGOT) UPTO 35.00 U/L 21
Serum Alkaline Phosphatase 50.00 - 116.00 U/L 77
Serum Gamma GT UPTO 59.00 U/L 46
Serum Total Protein 6.00 - 8.50 g/dL 7.5
Serum Albumin 3.50 - 5.00 g/dL 4.2
Serum Globulins 1.80 - 3.50 g/dL 3.3
A/G Ratio 1.00 - 2.20 1.3
Note: The changes in reference values are effective from 21 October 2019.

Dr. Hijab Batool Dr. M. Dilawar Khan

Consultant Chemical Pathologist Consultant Chemical Pathologist

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 info@chughtailab.com 07 - Jail Road Main Gulberg-III, Lahore www.chughtailab.com